Samuel R Saks Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Samuel R Saks.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Samuel R Saks. Samuel R Saks is a Director in PDL BIOPHARMA, INC. ($PDLI) and a Director in DEPOMED INC ($DMI) and a Chief Development Officer in Protagonist Therapeutics, Inc ($PTGX) and a Chief Medical Officer in Protagonist Therapeutics, Inc ($PTGX) and a Director in Tonix Pharmaceuticals Holding Corp. ($TNXP) and a Chief Development Officer in Auspex Pharmaceuticals, Inc. ($ASPX).
Address: JAZZ PHARMACEUTICALS, INC., 3180 PORTER DRIVE PALO ALTO 94304 CA
Companies in which Samuel R Saks is an Insider
Assertio Therapeutics, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Samuel R Saks: Director
Holdings: 5,099 shares
Latest Transaction: May 20 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Auspex Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Samuel R Saks: Chief Development Officer
Holdings: 0 shares
Latest Transaction: May 06 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Samuel R Saks: Director
Holdings: 214,190 shares
Current Value: $473,360
Latest Transaction: Jun 24 2019
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protagonist Therapeutics, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Samuel R Saks: Chief Medical Officer, Chief Development Officer
Holdings: 14,000 shares
Current Value: $250,600
Latest Transaction: Feb 26 2021
$PTGX Market Capitalization: $282.80M
$PTGX Previous Close: $17.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tonix Pharmaceuticals Holding Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Samuel R Saks: Director
Holdings: 6,605 shares
Current Value: $3,501
Latest Transaction: Jun 13 2018
$TNXP Market Capitalization: $21.31M
$TNXP Previous Close: $0.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Samuel R Saks
Sentiment: All, DMI, ASPX, PDLI, PTGX, TNXP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Option Exercise | A | 23.57 | 90,000 | 2,121,300 | 90,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Grant | A | 0.00 | 12,000 | 0 | 14,000 | 2 K to 14 K (+600.00 %) |
| Feb 28 2020 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Option Exercise | A | 7.80 | 85,000 | 663,000 | 85,000 | |
| Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | Saks Samuel R | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
| Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | Saks Samuel R | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
| May 16 2019 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Option Exercise | A | 10.80 | 45,000 | 486,000 | 45,000 | |
| Mar 04 2019 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Development O ... | Option Exercise | A | 8.02 | 15,000 | 120,300 | 15,000 |